Meridian Bioscience Inc. | Cash Flow
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
38,032.00
34,743.00
35,540.00
32,229.00
21,557.00
23,849
Depreciation, Depletion & Amortization
7,152.00
7,264.00
6,609.00
7,718.00
9,090.00
8,688
Other Funds
2,752.00
1,009.00
2,614.00
-
-
3,402
Funds from Operations
45,253.00
45,786.00
45,445.00
43,284.00
42,130.00
35,639
Changes in Working Capital
817.00
7,524.00
2,636.00
6,061.00
775.00
856
Net Operating Cash Flow
44,436.00
38,262.00
42,809.00
37,223.00
41,355.00
34,783
Capital Expenditures
3,277.00
7,002.00
4,764.00
4,004.00
4,467.00
Sale of Fixed Assets & Businesses
-
-
1,138.00
-
-
Purchase/Sale of Investments
-
-
-
600.00
-
Net Investing Cash Flow
3,277.00
7,002.00
3,626.00
66,695.00
4,467.00
Cash Dividends Paid - Total
31,354.00
32,762.00
33,357.00
33,649.00
24,266.00
Issuance/Reduction of Debt, Net
-
-
-
58,360.00
3,750.00
Net Financing Cash Flow
28,602.00
31,753.00
30,743.00
27,205.00
27,713.00
Net Change in Cash
12,689.00
1,235.00
6,926.00
2,747.00
9,846.00
Free Cash Flow
41,202.00
32,956.00
38,196.00
33,219.00
36,888.00
Deferred Taxes & Investment Tax Credit
1,823.00
140.00
122.00
233.00
1,474.00
300
Net Assets from Acquisitions
-
-
-
62,091.00
-
Change in Capital Stock
-
-
-
2,494.00
303.00
Exchange Rate Effect
132.00
742.00
1,514.00
480.00
671.00
About Meridian Bioscience
View Profile
